Two Sigma Advisers LP Acquires Shares of 19,350 Grail, Inc. (NASDAQ:GRAL)

Two Sigma Advisers LP acquired a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 19,350 shares of the company's stock, valued at approximately $345,000. Two Sigma Advisers LP owned 0.06% of Grail as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Crcm LP bought a new position in shares of Grail in the 4th quarter worth $65,061,000. Sessa Capital IM L.P. acquired a new stake in shares of Grail in the 4th quarter valued at approximately $53,550,000. Primecap Management Co. CA acquired a new position in Grail during the fourth quarter worth approximately $37,118,000. Baker BROS. Advisors LP bought a new position in shares of Grail in the fourth quarter valued at about $29,098,000. Finally, Vanguard Group Inc. acquired a new stake in Grail during the 4th quarter worth approximately $25,902,000.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on GRAL. Morgan Stanley upped their target price on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th. Canaccord Genuity Group boosted their price objective on Grail from $32.00 to $43.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th.

Insider Activity at Grail

In related news, President Joshua J. Ofman sold 48,213 shares of the stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $1,635,867.09. Following the sale, the president now owns 511,460 shares of the company's stock, valued at approximately $17,353,837.80. This represents a 8.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Robert P. Ragusa sold 94,035 shares of the stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $3,190,607.55. Following the completion of the sale, the chief executive officer now owns 734,627 shares in the company, valued at $24,925,894.11. This represents a 11.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 183,398 shares of company stock worth $6,222,694. Insiders own 1.85% of the company's stock.

Grail Trading Up 4.4%

Shares of NASDAQ:GRAL traded up $1.67 during mid-day trading on Monday, hitting $40.03. 2,590,774 shares of the company traded hands, compared to its average volume of 1,269,007. The stock has a 50-day moving average price of $33.24 and a two-hundred day moving average price of $29.32. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99. The stock has a market cap of $1.44 billion and a P/E ratio of -0.66.

Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, topping analysts' consensus estimates of ($4.03) by $0.93. The business had revenue of $31.84 million for the quarter, compared to the consensus estimate of $35.80 million. As a group, analysts expect that Grail, Inc. will post -15.15 earnings per share for the current year.

Grail Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.